Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cholestatic liver toxicity is a complex process, as it can be triggered by a variety of factors that induce 2 types of biological responses, namely a deteriorative response, caused by bile acid accumulation, and an adaptive response, aimed at removing the accumulated bile acids. Several key events in both types of responses have been characterized in the past few years. In parallel, many efforts have focused on the development and further optimization of experimental cell culture models to predict the occurrence of drug-induced cholestatic liver toxicity in vivo. In this paper, a state-of-the-art overview of mechanisms and in vitro models of dru...
There are many causes of cholestasis, which results when the flow of bile acids is slowed or stopped...
Drug-induced liver injury (DILI) is a common reason for drug withdrawal from the market. An importan...
Drug-induced cholestasis is an important form of acquired liver disease and is associated with signi...
Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cho...
Cholestatic liver insults constitute a major manifestation of drug-induced liver injury. Current in ...
Early detection of drug-induced cholestasis remains a challenge during drug development. We have dev...
Cholestasis is a reduction in bile flow that occurs during numerous pathologies. Cholestasis leads t...
Drugs are often withdrawn from the market due to the manifestation of drug-induced liver injury (DIL...
Drug-induced cholestasis (DIC) is one of the leading manifestations of drug-induced liver injury (DI...
La cholestase intrahépatique représente environ 40% des lésions hépatiques induites par les médicame...
Drug-induced liver injury remains the most common cause of acute liver failure and a frequently indi...
The liver is a heterogeneous organ with many vital functions, including metabolism of pharmaceutical...
In vitro models for hepatotoxicity testing are a necessity for advancement of toxicological research...
Hepatotoxicity is one of the major reasons for withdrawal of drugs from the market. Therefore, there...
Adverse outcome pathways (AOPs) have been recently introduced as tools to map the mechanisms underly...
There are many causes of cholestasis, which results when the flow of bile acids is slowed or stopped...
Drug-induced liver injury (DILI) is a common reason for drug withdrawal from the market. An importan...
Drug-induced cholestasis is an important form of acquired liver disease and is associated with signi...
Cholestasis underlies one of the major manifestations of drug-induced liver injury. Drug-induced cho...
Cholestatic liver insults constitute a major manifestation of drug-induced liver injury. Current in ...
Early detection of drug-induced cholestasis remains a challenge during drug development. We have dev...
Cholestasis is a reduction in bile flow that occurs during numerous pathologies. Cholestasis leads t...
Drugs are often withdrawn from the market due to the manifestation of drug-induced liver injury (DIL...
Drug-induced cholestasis (DIC) is one of the leading manifestations of drug-induced liver injury (DI...
La cholestase intrahépatique représente environ 40% des lésions hépatiques induites par les médicame...
Drug-induced liver injury remains the most common cause of acute liver failure and a frequently indi...
The liver is a heterogeneous organ with many vital functions, including metabolism of pharmaceutical...
In vitro models for hepatotoxicity testing are a necessity for advancement of toxicological research...
Hepatotoxicity is one of the major reasons for withdrawal of drugs from the market. Therefore, there...
Adverse outcome pathways (AOPs) have been recently introduced as tools to map the mechanisms underly...
There are many causes of cholestasis, which results when the flow of bile acids is slowed or stopped...
Drug-induced liver injury (DILI) is a common reason for drug withdrawal from the market. An importan...
Drug-induced cholestasis is an important form of acquired liver disease and is associated with signi...